Viking Therapeutics, Inc. (NASDAQ:VKTX) Reports PEG Ratio Of -0.0300
First Call posted that Viking Therapeutics, Inc. (NASDAQ:VKTX) can touch $6.7500 in coming year. However, for the upcoming quarter, the earnings projection is $-0.2100 per share and for ongoing fiscal, it is $-0.9900. For next year, the EPS target is $-0.9500 versus the reported EPS of $-2.8030 in the lastRead More